Henry Schein Inc (HSIC)
Industry Medical Distribution
This stock can be held in an Investment ISA and an Investment Account
Sell
$69.70
Buy
$71.43
$1.01 (+1.45%)
Henry Schein Inc is a provider of healthcare products and services to office-based dental, animal health and medical practitioners. The company also serves dental laboratories, government and institutional health care clinics.
Prices updated at 03 Jun 2025, 21:20 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
8,883m | 9,418m | 9,986m | 10,119m | 12,401m | 12,647m | 12,339m | 12,673m | |
2,747m | 2,911m | 3,091m | 2,814m | 3,674m | 3,831m | 3,860m | 4,016m | |
675m | 693m | 733m | 567m | 860m | 878m | 695m | 731m | |
7.60 | 7.36 | 7.34 | 5.61 | 6.93 | 6.94 | 5.63 | 5.77 | |
406m | 536m | 695m | 404m | 631m | 538m | 416m | 390m | |
815m | 756m | 916m | 727m | 1,068m | 950m | 851m | 912m | |
Sales, General and administrative | 2,072m | 2,217m | 2,358m | 2,247m | 2,634m | 2,771m | 2,956m | 3,034m |
Interest expenses | 51m | 76m | 51m | 41m | 27m | 35m | 87m | 131m |
Provision for income taxes | 309m | 107m | 160m | 95m | 198m | 170m | 120m | 128m |
Operating expenses | 2,072m | 2,217m | 2,358m | 2,247m | 2,814m | 2,953m | 3,165m | 3,285m |
Income before taxes | 630m | 537m | 680m | 500m | 831m | 721m | 542m | 513m |
Net income available to common shareholders | 406m | 536m | 695m | 404m | 631m | 538m | 416m | 390m |
2.59 | 3.51 | 4.7 | 2.83 | 4.51 | 3.95 | 3.18 | 3.07 | |
Net interest income | -39m | -61m | -35m | -32m | -21m | -27m | -70m | -107m |
Advertising and promotion | - | - | - | - | - | - | - | - |
Net investment income, net | - | - | - | - | - | - | - | - |
Realised capital gains (losses), net | - | - | - | - | - | - | - | - |
Total benefits, claims and expenses | - | - | - | - | - | - | - | - |
Earnings per share (diluted) | 2.57 | 3.49 | 4.65 | 2.82 | 4.45 | 3.91 | 3.16 | 3.05 |
Free cash flow per share | 2.9105 | 3.499 | 3.7515 | 3.3026 | 5.072 | 3.7953 | 4.8796 | 3.2633 |
Book value/share | 19.5955 | 19.6374 | 19.7381 | 22.1481 | 25.214 | 27.3991 | 28.2481 | 28.2145 |
Debt equity ratio | 0.322873 | 0.331048 | 0.266565 | 0.225347 | 0.315036 | 0.381602 | 0.614774 | 0.615679 |
Balance sheet
Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current assets | 4,033m | 4,175m | 3,227m | 3,791m | 3,844m | 3,988m | 4,488m | 3,983m |
Current liabilities | 2,776m | 3,219m | 2,038m | 2,283m | 2,307m | 2,224m | 2,683m | 2,803m |
Total capital | 3,719m | 3,965m | 3,621m | 3,864m | 4,236m | 4,486m | 5,592m | 5,223m |
Total debt | 1,666m | 1,964m | 998m | 1,002m | 1,217m | 1,497m | 2,741m | 2,870m |
Total equity | 2,811m | 2,961m | 2,998m | 3,348m | 3,425m | 3,446m | 3,655m | 3,393m |
Total non current liabilities | - | - | - | - | - | - | - | - |
Loans | 908m | 1,004m | 623m | 516m | 811m | 1,040m | 1,937m | 1,830m |
Total assets | 7,811m | 8,501m | 7,151m | 7,773m | 8,481m | 8,607m | 10,573m | 10,218m |
Total liabilities | - | - | - | - | - | - | - | - |
Cash and cash equivalents | 175m | 80m | 106m | 421m | 118m | 117m | 171m | 122m |
Common stock | 154m | 151m | 143m | 142m | 137m | 132m | 129m | 124m |
Cash flow
Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 62m | 175m | 57m | 106m | 421m | 118m | 117m | 171m |
Cash dividends paid | - | - | - | - | - | - | - | - |
464m | 594m | 578m | 550m | 631m | 506m | 313m | 661m | |
Investments (gains) losses | -342m | -193m | -424m | -115m | -677m | -276m | -1,135m | -430m |
175m | 80m | 106m | 421m | 118m | 117m | 171m | 122m | |
Net income | - | - | - | - | - | - | - | - |
546m | 685m | 654m | 599m | 710m | 602m | 500m | 848m | |
-82m | -91m | -76m | -49m | -79m | -96m | -187m | -187m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.